Clario develops and provides patient safety and efficacy endpoint data collection solutions for use in clinical drug development and clinical research needs. It offers clinical solutions in the areas of medical imaging, cardiac safety, precision motion, respiratory solutions, trial enablement, and decentralized trials. The company also provides eCOA digital solutions, eCOA live, eCOA multimedia, eCOA rescue studies, and suicidal ideation. It provides solutions for therapeutic areas such as cardiovascular and metabolic, dermatology, gastroenterology, hepatology, infectious diseases, musculoskeletal, neuroscience, oncology, ophthalmology, and respiratory. Clario was formerly known as eResearchTechnology, Inc. and changed its name to Clario in January 2022. The company was founded in 1972 and is based in Philadelphia, Pennsylvania, with additional locations in the United States, the United Kingdom, Belgium, Germany, Switzerland, India, China, and Japan.